Aprepitant Capsule, USP, 40 mg, 1 capsule per unit dose package, Rx only, MFG: Sandoz Pharma, NDC 0781-2321-06
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical Inc. is recalling Aprepitant Capsule, USP, 40 mg capsules distributed nationwide across 29 boxes due to temperature abuse during storage that violated good manufacturing practice standards. The product is a prescription medication manufactured by Sandoz Pharma. The company was unable to identify specific lot numbers received by individual customers, but provided distribution dates to help affected facilities determine whether they received impacted product.
The recall notice does not specify a remedy or recommended action for affected consumers or healthcare facilities.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 29 boxes Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.